Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Investigation of neuronal basis underlying antidepressant effect of serotonergic psychedelics

Daisuke Ibi

Proceedings for Annual Meeting of The Japanese Pharmacological Society January 1, 2022 DOI: 10.1254/jpssuppl.95.0_3-s35-1 (opens in new tab) via OpenAlex

Summary

AI-generated from the abstract

The FDA has approved psilocybin, the psychoactive compound in magic mushrooms, as a breakthrough therapy for depression, but its detailed mechanism remains unknown. Serotonergic psychedelics like psilocybin and LSD produce hallucinatory effects by stimulating the serotonin 5-HT2A receptor. In mice, 5-HT2A agonists such as DOI and psilocin (the active metabolite of psilocybin) reduced immobility time in the forced-swim test, an effect absent when the 5-HT2A gene was knocked down in the lateral septum. Activating Gq signaling in 5-HT2A-positive neurons in the lateral septum produced antidepressant and anxiolytic effects. Most 5-HT2A-positive cells in the lateral septum are GABAergic inhibitory neurons, suggesting their activation underlies the antidepressant effect.

Study at a glance

Characteristics Experimental study in mice Peer reviewed
Population Mice
Interventions DOI psilocin CNO
Topics Psilocybin Serotonin
Keywords Pharmacology Antidepressant
Key finding Activation of 5-HT2A-positive GABAergic neurons in the lateral septum mediates the antidepressant effect of serotonergic psychedelics in mice.

Abstract

Recently, FDA approved psilocybin, the psychoactive substance found in the magic mushroom, as a "breakthrough therapy" for depression; however, its detailed mechanism remains unknown. Serotonergic psychedelics such as psilocybin and LSD have hallucinatory effect through stimulation of serotonin 5-HT2A receptor (5-HT2A), motivating us to investigate the role of 5-HT2A stimulation in antidepressant effect of serotonergic psychedelics as well as its neural basis in mice. We demonstrated that 5-HT2A agonists such as DOI and psilocin, an active metabolite of psilocybin, decreased immobility time in the forced-swim test (FST), which was absent in mice with knockdown of Htr2a (5-HT2A gene) in the lateral septum (LS) by AAV-delivered shRNA. Since 5-HT2A is a Gq-coupled GPCR, we next investigated the effect of Gq signaling activation in 5-HT2A-positive neurons in LS on emotional behaviors in mice, for which hM3Dq, a Gq-coupled designer receptor activated by CNO, was transfected into 5-HT2A-positive neurons in LS of Htr2a-cre mice by microinjection of cre-dependent AAV. Activation of the hM3Dq with CNO induced antidepressant and anxiolytic effects in mice. Further, we found that most of 5-HT2A-positive cells in LS were the GABAergic inhibitory neurons, suggesting that activation of 5-HT2A-positive GABAergic neurons in LS leads to antidepressant effect. In this symposium, I would like to introduce the role of 5-HT2A in LS in not only antidepressant effect but also hallucination of serotonergic psychedelics.

Explore topics

Comments

No comments yet.

Log in to comment